Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

NCT ID: NCT00668083

Last Updated: 2010-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

214 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-09-30

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

second line Prostate Cancer bicalutamide biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non metastatic Prostate Cancer
* previous treatment with bicalutamide 150mg
* biochemical relapse/progression

Exclusion Criteria

* use of other treatments for Prostate Cancer
Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Davide Meani, MD

Role: STUDY_DIRECTOR

AstraZeneca Medical Dept

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Acquaviva delle Fonti, , Italy

Site Status

Research Site

Ancona, , Italy

Site Status

Research SIte

Florence, , Italy

Site Status

Research Site

Matera, , Italy

Site Status

Research Site

Messina, , Italy

Site Status

Research Site

Milan, , Italy

Site Status

Research Site

Monza, , Italy

Site Status

Research Site

Napoli, , Italy

Site Status

Research Site

Pisa, , Italy

Site Status

Research Site

Portogruaro, , Italy

Site Status

Research Site

Roma, , Italy

Site Status

Research Site

Viareggio, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-OIT-CAS-2007/1

Identifier Type: -

Identifier Source: org_study_id